News

This expanded program will combine the strength of the iBioLaunch platform with Novici’s patented GRAMMR technology for rapid evolution of gene sequences to significantly increase expression yield of

In 2007 CHPA members voluntarily withdrew infant cough and cold products and added further voluntary label changes in 2008 for use only in children ages 4 and older.

Plandaí’s unique and proprietary process known as "hydrodynamic sheering" which unzips the molecules of the "live" green tea plant, releases all of the phytonutrients, and then rearranges the

The fully human antibody, recovered from patients undergoing cancer vaccine treatment at Memorial Sloan-Kettering Cancer Center, has entered GMP manufacturing to produce clinical trial supplies for a planned

Dekel’s product candidates target indications including chronic pain and inflammation. In addition to its cannabinoid-related R&D drug programs, Dekel holds the IP rights to a disposable, dose-controlled inhalation

Around 80 patients will be enrolled in the trial across three sites including The University of Texas MD Anderson Cancer Center, the Sarah Cannon Research Institute and the

The approval allows the use of the Cook Pharmica manufacturing facility in Bloomington, Indiana for the production of bulk rHuPH20, the active ingredient used in Hylenex, and the

Xiaflex is approved in the US, EU, Canada and Australia to treat adult DC patients with a palpable cord. Dupuytren’s contracture is a progressive hand disease that can

LAL Deficiency is a serious, under-diagnosed disease with significant morbidity and early mortality. A rolling submission enables completed portions of the application to be submitted and reviewed on